TECH·09073M104·US·equity·Healthcare - Biotechnology-13D/G
TECH (BIO-TECHNE CORP) is held by 218 institutional investors as of Q1 2026. Net institutional sentiment: Mixed.
See how TECH's score breaks down across 4 SEC sources
No institutional holders are currently tracking this security.
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer